These findings largely phenocopied the Bmi1 knockdown [20], thus supporting that PTC-209 might selectively target the CSCs subpopulation via reducing Bmi1 in HNSCC. This evidence concerns the gene BMI1 and head and neck squamous cell carcinoma.